Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2012, Article ID 236981, 9 pages
http://dx.doi.org/10.1155/2012/236981
Review Article

Genetic Factors of Autoimmune Thyroid Diseases in Japanese

Division of Diabetes, Metabolism, and Endocrinology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan

Received 20 September 2011; Revised 31 October 2011; Accepted 31 October 2011

Academic Editor: Juan-Manuel Anaya

Copyright © 2012 Yoshiyuki Ban. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer, “Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms,” Endocrine Reviews, vol. 29, no. 6, pp. 697–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. L. Jacobson, S. J. Gange, N. R. Rose, and N. M. H. Graham, “Epidemiology and estimated population burden of selected autoimmune diseases in the United States,” Clinical Immunology and Immunopathology, vol. 84, no. 3, pp. 223–243, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. A. P. Weetman, “Chronic autoimmune thyroiditis,” in Werner and Ingbar’s The Thyroid, L. E. Braverman and R. D. Utiger, Eds., pp. 721–732, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2000. View at Google Scholar
  4. F Menconi, Y. L. Oppenheim, and Y. Tomer, “Graves’ disease,” in Diagnostic Criteria in Autoimmune Diseases, Y. Shoenfeld, R. Cervera, and M. E. Gershwin, Eds., pp. 231–235, Humana Press, Totowa, NJ, USA, 2008. View at Google Scholar
  5. Y. Tomer and T. F. Davies, “Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function,” Endocrine Reviews, vol. 24, no. 5, pp. 694–717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Stenszky, L. Kozma, C. Balazs, S. Rochlitz, J. C. Bear, and N. R. Farid, “The genetics of Graves' disease: HLA and disease susceptibility,” The Journal of Clinical Endocrinology & Metabolism, vol. 61, pp. 735–740, 1985. View at Google Scholar
  7. A. Mangklabruks, N. Cox, and L. J. DeGroot, “Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes,” The Journal of Clinical Endocrinology & Metabolism, vol. 73, no. 2, pp. 236–244, 1991. View at Google Scholar · View at Scopus
  8. J. M. Heward, A. Allahabadia, J. Daykin et al., “Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 10, pp. 3394–3397, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Menconi, M. C. Monti, D. A. Greenberg et al., “Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 37, pp. 14034–14039, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. A. A. Zeitlin, J. M. Heward, P. R. Newby et al., “Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease,” Genes & Immunity, vol. 9, no. 4, pp. 358–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Ban, T. F. Davies, D. A. Greenberg et al., “Arginine at position 74 of the HLA-DR β1 chain is associated with Graves' disease,” Genes & Immunity, vol. 5, no. 3, pp. 203–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Simmonds, J. M. M. Howson, J. M. Heward et al., “Regression mapping of association between the human leukocyte antigen region and Graves disease,” The American Journal of Human Genetics, vol. 76, no. 1, pp. 157–163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Simmonds, J. M. M. Howson, J. M. Heward et al., “A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect,” Human Molecular Genetics, vol. 16, no. 18, pp. 2149–2153, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman, and L. J. DeGroot, “CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population,” The Journal of Clinical Endocrinology & Metabolism, vol. 80, no. 1, pp. 41–45, 1995. View at Google Scholar · View at Scopus
  15. H. Ueda, J. M. M. Howson, L. Esposito et al., “Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease,” Nature, vol. 423, no. 6939, pp. 506–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Tomer, E. Concepcion, and D. A. Greenberg, “A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease,” Thyroid, vol. 12, no. 12, pp. 1129–1135, 2002. View at Google Scholar · View at Scopus
  17. D. Smyth, J. D. Cooper, J. E. Collins et al., “Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus,” Diabetes, vol. 53, no. 11, pp. 3020–3023, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Tomer, D. A. Greenberg, E. Concepcion, Y. Ban, and T. F. Davies, “Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 1, pp. 404–407, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Collins, J. M. Heward, J. Carr-Smith, J. Daykin, J. A. Franklyn, and S. C. L. Gough, “Association of a Rare Thyroglobulin Gene Microsatellite Variant with Autoimmune Thyroid Disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 10, pp. 5039–5042, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. B. M. Dechairo, D. Zabaneh, J. Collins et al., “Association of the TSHR gene with Graves' disease: the first disease specific locus,” European Journal of Human Genetics, vol. 13, no. 11, pp. 1223–1230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Gebe, E. Swanson, and W. W. Kwok, “HLA class II peptide-binding and autoimmunity,” Tissue Antigens, vol. 59, no. 2, pp. 78–87, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. E. M. Jacobson, A. Huber, and Y. Tomer, “The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology,” Journal of Autoimmunity, vol. 30, no. 1-2, pp. 58–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Saito, S. Ota, E. Yamada, H. Inoko, and M. Ota, “Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population,” Tissue Antigens, vol. 56, no. 6, pp. 522–529, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. R. P. Dong, A. Kimura, R. Okubo et al., “HLA-A and DPB1 loci confer susceptibility to Graves' disease,” Human Immunology, vol. 35, no. 3, pp. 165–172, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Takahashi, M. Yasunami, S. Kubota, H. Tamai, and A. Kimura, “HLA-DPB1*0202 is associated with a predictor of good prognosis of Graves' disease in the Japanese,” Human Immunology, vol. 67, no. 1-2, pp. 47–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. X. L. Wan, A. Kimura, R. P. Dong, K. Honda, H. Tamai, and T. Sasazuki, “HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis,” Human Immunology, vol. 42, no. 2, pp. 131–136, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Tomer, “Genetic susceptibility to autoimmune thyroid disease: past, present, and future,” Thyroid, vol. 20, no. 7, pp. 715–725, 2010. View at Google Scholar · View at Scopus
  28. R. Khattri, J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone, “Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses,” The Journal of Immunology, vol. 162, no. 10, pp. 5784–5791, 1999. View at Google Scholar · View at Scopus
  29. M. M. Sale, T. Akamizu, T. D. Howard et al., “Association of autoimmune thyroid disease with a microsatellite marker for the thyrotropin receptor gene and CTLA-4 in a Japanese population,” Proceedings of the Association of American Physicians, vol. 109, no. 5, pp. 453–461, 1997. View at Google Scholar · View at Scopus
  30. T. Yanagawa, M. Taniyama, S. Enomoto et al., “CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese,” Thyroid, vol. 7, no. 6, pp. 843–846, 1997. View at Google Scholar · View at Scopus
  31. K. Furugaki, S. Shirasawa, N. Ishikawa et al., “Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese,” Journal of Human Genetics, vol. 49, no. 3, pp. 166–168, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, and Y. Ban, “Association of a CTLA-4 3′ untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population,” Autoimmunity, vol. 38, no. 2, pp. 151–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. X. Zhao, C. M. Pan, H. M. Cao et al., “Association of the CTLA4 gene with Graves' disease in the Chinese Han population,” PloS one, vol. 5, no. 3, Article ID e9821, 2010. View at Google Scholar
  34. M. Takahashi and A. Kimura, “HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves disease,” Journal of Human Genetics, vol. 55, no. 5, pp. 323–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. M. Jacobson and Y. Tomer, “The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future,” Journal of Autoimmunity, vol. 28, no. 2-3, pp. 85–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, and Y. Ban, “Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves' disease in Japanese,” Thyroid, vol. 16, no. 5, pp. 443–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Mukai, Y. Hiromatsu, T. Fukutani et al., “A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese,” Endocrine Journal, vol. 52, no. 4, pp. 471–477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. A. Chung and L. A. Criswell, “PTPN22: its role in SLE and autoimmunity,” Autoimmunity, vol. 40, no. 8, pp. 582–590, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, and Y. Ban, “The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese,” Thyroid, vol. 15, no. 10, pp. 1115–1118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Kawasaki, T. Awata, H. Ikegami et al., “Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations,” American Journal of Medical Genetics, vol. 140, no. 6, pp. 586–593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Ichimura, H. Kaku, T. Fukutani et al., “Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population,” Thyroid, vol. 18, no. 6, pp. 625–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. V. E. Carlton, X. Hu, A. P. Chokkalingam et al., “PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis,” The American Journal of Human Genetics, vol. 77, no. 4, pp. 567–581, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Ichimura, H. Kaku, T. Fukutani et al., “Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population,” Thyroid, vol. 18, no. 6, pp. 625–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Ban, T. Tozaki, M. Taniyama et al., “Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population,” Thyroid, vol. 20, no. 8, pp. 893–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Shirasawa, H. Harada, K. Furugaki et al., “SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease,” Human Molecular Genetics, vol. 13, no. 19, pp. 2221–2231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Sakai, S. Shirasawa, N. Ishikawa et al., “Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese,” Human Molecular Genetics, vol. 10, no. 13, pp. 1379–1386, 2001. View at Google Scholar · View at Scopus
  47. M. Koyanagi, K. Nakabayashi, T. Fujimoto et al., “ZFAT expression in B and T lymphocytes and identification of ZFAT-regulated genes,” Genomics, vol. 91, no. 5, pp. 451–457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Fujimoto, K. Doi, M. Koyanagi et al., “ZFAT is an antiapoptotic molecule and critical for cell survival in MOLT-4 cells,” FEBS Letters, vol. 583, no. 3, pp. 568–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. R. S. Davis, “Fc receptor-like molecules,” Annual Review of Immunology, vol. 25, pp. 525–560, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Marrack, J. Kappler, and B. L. Kotzin, “Autoimmune disease: why and where it occurs,” Nature Medicine, vol. 7, no. 8, pp. 899–905, 2001. View at Publisher · View at Google Scholar
  51. Y. Kochi, R. Yamada, A. Suzuki et al., “A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities,” Nature Genetics, vol. 37, no. 5, pp. 478–485, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. M. J. Simmonds, J. M. Heward, J. Carr-Smith, H. Foxall, J. A. Franklyn, and S. C. Gough, “Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 3, pp. 1056–1061, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. Wellcome Trust Case Control Consortium, “Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants,” Nature Genetics, vol. 39, pp. 1329–1337, 2007. View at Google Scholar
  54. Y. Ban, T. Tozaki, M. Taniyama et al., “Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population,” Autoimmunity, vol. 42, no. 2, pp. 126–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Ban, T. Tozaki, M. Taniyama, Y. Nakano, Y. Ban, and T. Hirano, “Genomic polymorphism in the interferon-induced helicase (IFIH1) gene does not confer susceptibility to autoimmune thyroid disease in the Japanese population,” Hormone and Metabolic Research, vol. 42, no. 1, pp. 70–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Ban, T. Tozaki, T. Tobe et al., “The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts,” Journal of Autoimmunity, vol. 28, no. 4, pp. 201–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. C. S. Lankford and D. M. Frucht, “A unique role for IL-23 in promoting cellular immunity,” Journal of Leukocyte Biology, vol. 73, no. 1, pp. 49–56, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. R. H. Duerr, K. D. Taylor, S. R. Brant et al., “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene,” Science, vol. 314, no. 5804, pp. 1461–1463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. B. Faragó, L. Magyari, E. Sáfrány et al., “Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 67, no. 2, pp. 248–250, 2008. View at Publisher · View at Google Scholar
  60. M. Cargill, S. J. Schrodi, M. Chang et al., “A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes,” The American Journal of Human Genetics, vol. 80, no. 2, pp. 273–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. A. K. Huber, E. M. Jacobson, K. Jazdzewski, E. S. Concepcion, and Y. Tomer, “IL-23R is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/Th17 axis extends to thyroid autoimmunity,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 3, pp. 1077–1081, 2008. View at Google Scholar
  62. M. Yoneyama, M. Kikuchi, K. Matsumoto et al., “Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity,” The Journal of Immunology, vol. 175, no. 5, pp. 2851–2858, 2005. View at Google Scholar · View at Scopus
  63. E. Meylan, J. Tschopp, and M. Karin, “Intracellular pattern recognition receptors in the host response,” Nature, vol. 442, no. 7098, pp. 39–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. M. Lonnrot, K. Korpela, M. Knip et al., “Enterovirus infections as a risk factor for β-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study,” Diabetes, vol. 49, no. 8, pp. 1314–1318, 2000. View at Google Scholar · View at Scopus
  65. D. J. Smyth, J. D. Cooper, R. Bailey et al., “A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region,” Nature Genetics, vol. 38, no. 6, pp. 617–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Sutherland, J. Davies, C. J. Owen et al., “Brief report: genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 8, pp. 3338–3341, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. J. A. Todd, N. M. Walker, J. D. Cooper et al., “Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes,” Nature Genetics, vol. 39, no. 7, pp. 857–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Tomer, G. Barbesino, D. A. Greenberg, E. Concepcion, and T. F. Davies, “Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions,” The Journal of Clinical Endocrinology & Metabolism, vol. 84, no. 12, pp. 4656–4664, 1999. View at Google Scholar · View at Scopus
  69. J. C. Taylor, S. C. Gough, P. J. Hunt et al., “A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 2, pp. 646–653, 2006. View at Publisher · View at Google Scholar
  70. H. Imrie, B. Vaidya, P. Perros et al., “Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 2, pp. 626–630, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Tomer, Y. Ban, E. Conception et al., “Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families,” The American Journal of Human Genetics, vol. 73, no. 4, pp. 736–747, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. G. C. Ebers, K. Kukay, D. E. Bulman et al., “A full genome search in multiple sclerosis,” Nature Genetics, vol. 13, no. 4, pp. 472–476, 1996. View at Publisher · View at Google Scholar
  73. F. Cornélis, S. Fauré, M. Martinez et al., “New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 18, pp. 10746–10750, 1998. View at Google Scholar · View at Scopus
  74. F. Cucca, J. V. Goy, Y. Kawaguchi et al., “A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients,” Nature Genetics, vol. 19, no. 3, pp. 301–302, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. W. M. Bassuny, K. Ihara, Y. Sasaki et al., “A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes,” Immunogenetics, vol. 55, no. 3, pp. 149–156, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. P. Zavattari, E. Deidda, M. Pitzalis et al., “No association between variation of the FOXP3 gene and common type 1 diabetes in the Sardinian population,” Diabetes, vol. 53, no. 7, pp. 1911–1914, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. C. J. Owen, J. A. Eden, C. E. Jennings, V. Wilson, T. D. Cheetham, and S. H. S. Pearce, “Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population,” Journal of Molecular Endocrinology, vol. 37, no. 1, pp. 97–104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Inoue, M. Watanabe, M. Morita et al., “Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases,” Clinical & Experimental Immunology, vol. 162, no. 3, pp. 402–406, 2010. View at Google Scholar
  79. H. P. Kim, J. Imbert, and W. J. Leonard, “Both integrated and differential regulation of components of the IL-2/IL-2 receptor system,” Cytokine & Growth Factor Reviews, vol. 17, no. 5, pp. 349–366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Vella, J. D. Cooper, C. E. Lowe et al., “Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms,” The American Journal of Human Genetics, vol. 76, no. 5, pp. 773–779, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. O. J. Brand, C. E. Lowe, J. M. Heward et al., “Association of the interleukin-2 receptor α (IL-2Rα)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs,” Clinical Endocrinology, vol. 66, no. 4, pp. 508–512, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. The Wellcome Trust Case Control Consortium , “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,” Nature, vol. 447, no. 7145, pp. 661–678, 2007. View at Publisher · View at Google Scholar
  83. D. A. Hafler, A. Compston, S. Sawcer et al., “Risk alleles for multiple sclerosis identified by a genomewide study,” The New England Journal of Medicine, vol. 357, no. 9, pp. 851–862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  84. E. Kawasaki, T. Awata, H. Ikegami et al., “Genetic association between the lnterleukin-2 receptor-α gene and mode of onset of type 1 diabetes in the Japanese population,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 3, pp. 947–952, 2009. View at Publisher · View at Google Scholar
  85. Y. Ban, D. A. Greenberg, E. Concepcion, L. Skrabanek, R. Villanueva, and Y. Tomer, “Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15119–15124, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Ban, T. Tozaki, M. Taniyama, M. Tomita, and Y. Ban, “Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population,” Clinical Endocrinology, vol. 61, no. 2, pp. 263–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. A. A. Zeitlin, M. J. Simmonds, and S. C. L. Gough, “Genetic developments in autoimmune thyroid disease: an evolutionary process,” Clinical Endocrinology, vol. 68, no. 5, pp. 671–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. B. M. Dechairo, D. Zabaneh, J. Collins et al., “Association of the TSHR gene with Graves' disease: the first disease specific locus,” European Journal of Human Genetics, vol. 13, no. 11, pp. 1223–1230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. O. J. Brand, J. C. Barrett, M. J. Simmonds et al., “Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease,” Human Molecular Genetics, vol. 18, no. 9, pp. 1704–1713, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. R. Płoski, O. J. Brand, B. Jurecka-Lubieniecka et al., “Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European caucasian cohorts,” PLoS One, vol. 5, no. 11, Article ID e15512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. H. Hiratani, D. W. Bowden, S. Ikegami et al., “Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease,” The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 5, pp. 2898–2903, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. Y. Kochi, A. Suzuki, R. Yamada, and K. Yamamoto, “Genetics of rheumatoid arthritis: underlying evidence of ethnic differences,” Journal of Autoimmunity, vol. 32, no. 3-4, pp. 158–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. R. H. Duerr, K. D. Taylor, S. R. Brant et al., “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene,” Science, vol. 314, no. 5804, pp. 1461–1463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. J. Hampe, A. Franke, P. Rosenstiel et al., “A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1,” Nature Genetics, vol. 39, no. 2, pp. 207–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. R. Sladek, G. Rocheleau, J. Rung et al., “A genome-wide association study identifies novel risk loci for type 2 diabetes,” Nature, vol. 445, no. 7130, pp. 881–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. P. M. Gaffney, G. M. Kearns, K. B. Shark et al., “A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14875–14879, 1998. View at Publisher · View at Google Scholar · View at Scopus
  97. E. Jorgenson and J. S. Witte, “A gene-centric approach to genome-wide association studies,” Nature Reviews Genetics, vol. 7, no. 11, pp. 885–891, 2006. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Steer, V. Abkevich, A. Gutin et al., “Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis,” Genes & Immunity, vol. 8, no. 1, pp. 57–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. L.-D. Sun, F.-L. Xiao, Y. Li et al., “Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population,” Nature Genetics, vol. 43, no. 7, pp. 690–694, 2011. View at Publisher · View at Google Scholar